Ignite Creation Date:
2024-05-06 @ 7:51 AM
Last Modification Date:
2024-10-26 @ 11:53 AM
Study NCT ID:
NCT02610777
Status:
COMPLETED
Last Update Posted:
2022-09-19
First Post:
2015-11-18
Brief Title:
An Efficacy and Safety Study of Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine in Participants With Higher-Risk Myelodysplastic Syndromes HR MDS Chronic Myelomonocytic Leukemia CMML and Low-Blast Acute Myelogenous Leukemia AML
Sponsor:
Millennium Pharmaceuticals Inc
Organization:
Takeda
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Leukemia Myeloid Acute |
| Myelodysplastic Syndromes |
| Leukemia Myelomonocytic Chronic |
Keywords:
| Name | View |
|---|---|
| Drug Therapy | View |